Почетна › Срцева слабост › Тексас
Клинички испитувања за Срцева слабост во Тексас
67 студии за Срцева слабост бараат учесници на локации во Тексас.
Градови во Тексас
- Dallas42 студии
- Houston36 студии
- Austin18 студии
- Plano11 студии
- Tyler8 студии
- Amarillo8 студии
- Fort Worth7 студии
- The Woodlands7 студии
- McKinney7 студии
- El Paso7 студии
- Killeen6 студии
- San Antonio6 студии
- Waco4 студии
- Grand Prairie4 студии
- Denison4 студии
- Cypress3 студии
- McAllen3 студии
Официјален текст на студијата (англиски)
Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure
- Heart Hospital Baylor Plano, Plano
- Christus Trinity Mother Frances Health System, Tyler
Се регрутира
Возраст 18 и постари · Сите полови · Ажурирано 5.10.2026 · NCT07069738A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
- Amarillo Medical Specialists, Amarillo
- University of Texas Southwestern Medical Center, Dallas
- Texama Medical Center, Denison
- и уште 1
Се регрутираФаза 2
Возраст од 40 до 84 · Сите полови · Ажурирано 5.10.2026 · NCT06979362ELEVATE-HFpEF Clinical Study
- Dallas VA Medical Center, Dallas
- Texas Health Research & Education Institute, Fort Worth
Се регрутира
Возраст 40 и постари · Сите полови · Ажурирано 2.10.2026 · NCT06678841Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
- Research Site, Allen
- Research Site, Amarillo
- Research Site, Amarillo
- и уште 13
Се регрутираФаза 3
Возраст од 18 до 130 · Сите полови · Ажурирано 2.10.2026 · NCT06307652A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
- Pharmatex Research, Amarillo
- Amarillo Heart Clinical Research Institute, Incorporated, Amarillo
- Texas Health Research and Education Institute, Dallas
- и уште 8
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 1.10.2026 · NCT06424288A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
- Pharmatex Research, Amarillo
- Amarillo Heart Clinical Research Institute, Incorporated, Amarillo
- NextStage Clinical Research, Beaumont
- и уште 13
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 1.10.2026 · NCT06935370NT-ProBNP-based Heart Failure Screening and Prevention Trial in Patients With Type 2 Diabetes: STRONG-DM Study
- University of Texas Southwestern Medical Center, Dallas
- Parkland Health & Hospital System (PHHS), Dallas
- Baylor Scott and White - Health System, Dallas
Се регрутира
Сите возрасти · Сите полови · Ажурирано 29.9.2026 · NCT06593327BiVACOR® Total Artificial Heart Early Feasibility Study
- Texas Heart Institute / Baylor St. Luke's Medical Center, Houston
Се регрутира
Возраст од 18 до 70 · Сите полови · Ажурирано 28.9.2026 · NCT06174103A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
- Research Site, Dallas
- Research Site, DeSoto
- Research Site, El Paso
- и уште 8
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 28.9.2026 · NCT07761117Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
- Baylor University Medical Center, Dallas
- The University of Texas Southwestern Medical Center, Dallas
- University of Texas Medical Branch - UTMB, Galveston
- и уште 2
Се регрутираФаза 3
Возраст од 18 до 85 · Сите полови · Ажурирано 24.9.2026 · NCT06736574Evaluation of Liver Stiffness Performance, by FibroScan®, to Detect Elevated Central Venous Pressure (CVP)
- University of Texas Southwestern Medical Center - Clinical Heart and Vascular Center - West Campus Building 3 Location, Dallas
Се регрутира
Возраст 18 и постари · Сите полови · Ажурирано 23.9.2026 · NCT07222813Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart Failure
- CHRISTUS Trinity Mother Frances, Tyler
Се регрутира
Возраст 18 и постари · Сите полови · Ажурирано 23.9.2026 · NCT07232030A Study of LY3971297 in Participants With Heart Failure
- Houston Methodist Hospital, Houston
Се регрутираФаза 1
Возраст од 18 до 65 · Сите полови · Ажурирано 22.9.2026 · NCT07547540Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- PharmaTex Research, LLC, Amarillo
- Austin Heart, Austin
- Javara Research, Conroe
- и уште 13
Се регрутираФаза 3
Возраст од 18 до 99 · Сите полови · Ажурирано 16.9.2026 · NCT07037459Alleviant ALLAY-HFrEF Study
- Hendrick Health, Abilene
- Austin Heart, Austin
- Baylor Scott & White Research Institute, Plano
- и уште 2
Се регрутира
Возраст 18 и постари · Сите полови · Ажурирано 16.9.2026 · NCT06812533Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
- Research Site, Austin
- Research Site, Beaumont
- Research Site, Brownsville
- и уште 17
Се регрутираФаза 3
Возраст 40 и постари · Сите полови · Ажурирано 15.9.2026 · NCT06677060Novel Technologies to Improve Echocardiographic Estimates of Left Ventricular Filling Pressure in Heart Failure Combined With Atrial Fibrillation
- Methodist DeBakey Heart and Vascular Center, Houston
Се регрутираНабљудувачка студија
Возраст 18 и постари · Сите полови · Ажурирано 10.9.2026 · NCT07436299A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
- Amarillo, TX Investigative Site 10045, Amarillo
- Austin, TX Investigative Site 10015, Austin
- Dallas, TX Investigative Site 10042, Dallas
- и уште 2
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 10.9.2026 · NCT06008197A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
- CON-10045 Amarillo, TX Investigational Site, Amarillo
- CON-10015 Austin, TX Investigational Site, Austin
- CON-10304, Denison, TX, Denison
- и уште 4
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 10.9.2026 · NCT06024746The WiSE®-UP Study (The WiSE System Utilization & Performance Study)
- Texas Cardiac Arrhythmia Research Foundation, Austin
Се регрутираНабљудувачка студија
Возраст 22 и постари · Сите полови · Ажурирано 10.9.2026 · NCT07098858Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
- Baylor University Medical Center, part of Baylor Scott & White Health, Dallas
- UT southwestern Medical Center, Dallas
- Houston Methodist Hospital, Houston
- и уште 3
Се регрутира
Возраст од 18 до 100 · Сите полови · Ажурирано 9.9.2026 · NCT06310031A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)
- Local Institution - 167, Dallas
- Local Institution - 151, Houston
- Local Institution - 157, Houston
- и уште 1
Се регрутираФаза 2
Возраст од 30 до 84 · Сите полови · Ажурирано 31.8.2026 · NCT07795814Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
- Children's Health-The Heart Center ( Site 0015), Dallas
- Texas Children's Hospital ( Site 0039), Houston
Се регрутираФаза 2/3
29 Days – 17 Years · Сите полови · Ажурирано 28.8.2026 · NCT05714085AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF
- University of Texas Southwestern Medical Center, Dallas, Dallas
- Center for Advanced Heart Failure, Houston
Се регрутираФаза 2
Возраст од 40 до 85 · Сите полови · Ажурирано 27.8.2026 · NCT06793371Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
- Texas Heart Institute, Houston
Се регрутира
Возраст 21 и постари · Сите полови · Ажурирано 25.8.2026 · NCT05677100Optimal Pediatric Heart Transplant Immunosuppression With MicroRNAs
- Texas Children's Hospital, Houston
Се регрутираНабљудувачка студија
До возраст 18 · Сите полови · Ажурирано 25.8.2026 · NCT06532890Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
- Dell Children's Medical Center of Central Texas, Austin
Се регрутираНабљудувачка студијаДобредојдени се здрави волонтери
Возраст од 0 до 20 · Сите полови · Ажурирано 21.8.2026 · NCT04278404Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
- Austin
- Dallas
- Fort Worth
- и уште 3
Се регрутираНабљудувачка студија
Сите возрасти · Сите полови · Ажурирано 20.8.2026 · NCT00271180A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
- North Texas Cardiology Center, Dallas
- Baylor Scott & White Research Institute, Dallas
- The Methodist Hospital, Methodist Cancer Cencer, Houston
- и уште 3
Се регрутираНабљудувачка студија
Возраст 18 и постари · Сите полови · Ажурирано 19.8.2026 · NCT05489705LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
- Tenax Investigational Site, Austin
- Tenax Investigational Site, Dallas
- Tenax Investigational Site, El Paso
- и уште 1
Се регрутираФаза 3
Возраст од 18 до 85 · Сите полови · Ажурирано 19.8.2026 · NCT07288398A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- PharmaTex Research, LLC, Amarillo
- Austin Heart, Austin
- Javara Inc. / Privia Medical Group Gulf Coast PLLC, Conroe
- и уште 24
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 18.8.2026 · NCT07567001Alleviant ALLAY-HF Study
- Hendrick Health, Abilene
- Austin Heart, Austin
- UT Southwestern, Dallas
- и уште 2
Се регрутира
Возраст 40 и постари · Сите полови · Ажурирано 14.8.2026 · NCT05685303CSP #2025 - Geriatric OUt-of-hospital Randomized MEal Trial in Heart Failure: Veterans Affairs (GOURMET-VA)
- VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX, Dallas
- Michael E. DeBakey VA Medical Center, Houston, TX, Houston
Се регрутира
Возраст 60 и постари · Сите полови · Ажурирано 14.8.2026 · NCT05996328OPtimal Adult Heart Transplant Immunosuppression With MicroRNA Levels
- Baylor University Medical Center, Dallas
Се регрутираНабљудувачка студија
Возраст од 18 до 99 · Сите полови · Ажурирано 11.8.2026 · NCT06939751Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System
- Children's Health Dallas, Dallas
Се регрутираФаза 2
Возраст од 0 до 16 · Сите полови · Ажурирано 10.8.2026 · NCT06080074Assessment of CCM in HF With Higher Ejection Fraction
- Ascension Seton, Austin
- Austin Heart, Austin
- Baylor Scott and White Research Institute, Dallas
- и уште 7
Се регрутира
Возраст 18 и постари · Сите полови · Ажурирано 6.8.2026 · NCT05064709A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
- FIN-10015 Austin, TX Investigational Site, Austin
- FIN-10404, Denison, TX, Denison
- FIN-10085, Houston, TX, Houston
- и уште 1
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 10.7.2026 · NCT0603395018F-mFBG Imaging for Myocardial Sympathetic Innervation
- UT Health Houston, Houston
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 1.7.2026 · NCT06965621PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
- Austin Heart, Austin
- Medical City Healthcare Dallas, Dallas
- Baylor Scott & White -Dallas, Dallas
- и уште 3
Се регрутира
Возраст 18 и постари · Сите полови · Ажурирано 29.6.2026 · NCT05934487A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
- Children's Medical Center Dallas - Cardiology, Dallas
- Texas Children's Hospital - Cardiology, Houston
Се регрутираФаза 3
До возраст 18 · Сите полови · Ажурирано 29.6.2026 · NCT07192952Од ClinicalTrials.gov, податоци преземени 6.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.